GLP Watchdog

Best Liraglutide Providers in 2026: Ranked and Reviewed

Liraglutide is the one GLP-1 with generic versions on pharmacy shelves. Novo Nordisk sells it as Saxenda for weight and as Victoza for type 2 diabetes, and generic makers now hold approvals that copy each label. It is a daily injection, and in a head-to-head trial it produced far less weight loss than weekly semaglutide. FDA's shortage list still shows liraglutide injection in shortage, and lists Saxenda as available until its discontinuation in January 2027. Every seller below lists a liraglutide price, generic, brand or compounded, and the price shown is that one. A compounded version is not the same product as an approved generic, so check which one a seller means.

Lowest verified price: $149/mo7 providers compared

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

7 liraglutide providers compared · independently scored against our six-factor methodology.

Quick Picks

Starting price per provider. Prices in USD per month; checked October 2026.
#ProviderScore
1Factor Health MDVisit
2Bloom MDVisit
3AlloyVisit
4ShapeIn RxVisit
5Hone HealthVisit

Liraglutide: the labels, the trials and the supply

  • 8.4 kg vs 2.8 kg

    weight lost at 56 weeks, SCALE

    In SCALE, adults on liraglutide 3 mg a day lost an average of 8.4 kg, against 2.8 kg on placebo. That is the trial behind Saxenda's weight indication.[12]

    Saxenda label and prices →

  • 15.8% vs 6.4%

    weight change, semaglutide vs liraglutide

    STEP 8 put weekly semaglutide 2.4 mg against daily liraglutide 3 mg for 68 weeks. Weight fell 15.8% on semaglutide and 6.4% on liraglutide, and more people stopped liraglutide (27.6% against 13.5%).[13]

    Why a generic is not the whole story →

  • In shortage

    FDA list, first posted July 18, 2023

    FDA's drug shortage database lists liraglutide injection as currently in shortage. The same entry shows Saxenda with limited availability until its discontinuation in January 2027.[14]

    What generics exist →

  • 0.6 to 3 mg

    Saxenda's daily dose ladder

    Saxenda starts at 0.6 mg a day for one week and rises weekly to the recommended 3 mg a day, injected once daily at any time. A generic approved against the Saxenda label carries the same weight indication.[15]

    Saxenda dosing →

Compare the top providers at a glance

Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.

  • ★ Editor's Pick
    Factor Health MD

    compounded liraglutide, a daily injection

    From /mo
    $150prepaid
    Flat at every dose
    Coverage
    Check intake
    Medications
    Liraglutide
    Visit →
  • Bloom MD

    compounded liraglutide, a daily injection

    From /mo
    $395
    Coverage
    39 states + DC
    Medications
    Liraglutide
    Visit →
  • Alloy

    compounded liraglutide, a daily injection

    From /mo
    $214
    Coverage
    48 states + DC
    Medications
    Liraglutide
    Visit →
Show 4 more
  • Best Budget
    ShapeIn Rx

    compounded liraglutide, a daily injection

    From /mo
    $149
    Scales with dose
    Coverage
    Check intake
    Medications
    Liraglutide
    Visit →
  • Hone Health

    compounded liraglutide, a daily injection

    From /mo
    $160
    Coverage
    Check intake
    Medications
    Liraglutide
    Visit →
  • Better MedSpa

    , a daily injection

    From /mo
    $550
    Coverage
    1 state
    Medications
    Liraglutide
    Visit →
  • Cost Plus Drugs

    approved liraglutide (brand or generic), a daily injection

    From /mo
    $716.50
    Coverage
    Check intake
    Medications
    Liraglutide
    Visit →
6weighted dimensions
7liraglutide providers compared
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →

Detailed Reviews

1

Factor Health MD

Best for: compounded liraglutide, a daily injection

8.3

Compounded semaglutide costs $99.99 a month at Factor Health MD and compounded tirzepatide $189.99, the same at every dose. A 12-month plan paid up front lowers those to $79.99 and $149.99 a month. Compounded liraglutide runs $150 a month on a 3-month plan. Every patient has a video visit with a provider, and the St. Petersburg, Florida company also sells vitamin injectables and men's health products.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
7.5
Trust & Safety15%
6.5
Accessibility10%
5
Support10%
7

Pros

  • ✓Semaglutide costs $99.99 a month, 50% below the $199 median for compounded semaglutide across the sellers we compare
  • ✓Tirzepatide costs $189.99 a month, 29% below the $269 median for compounded tirzepatide across the sellers we compare
  • ✓Liraglutide costs $150 a month, close to the $160 median for compounded liraglutide across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price stays the same as your dose goes up
  • ✓The monthly price includes the medication, clinician visits and shipping
  • ✓We found no FDA warning letters issued to Factor Health MD
  • ✓A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake

Cons

  • ✗Confirm it serves your state before you start the intake
  • ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
  • ✗Its liraglutide, semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Starting from $150/mo, prepaidRead full review →
Visit Factor Health MD →
2

Bloom MD

Best for: compounded liraglutide, a daily injection

7.8

Bloom MD is a Utah wellness clinic that sells weight-loss, hormone and longevity care through an online store. Compounded semaglutide runs $270 a month on subscription at any dose, and compounded tirzepatide starts at $244 and climbs by dose to $459. Brand Wegovy, Zepbound and pill programs are sold as a $75 membership with the drug bought separately. It ships prescriptions to 39 states and DC.

Score Breakdown

Value25%
5.7
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
7.5
Accessibility10%
8.2
Support10%
7

Pros

  • ✓Tirzepatide costs $244 a month, 9% below the $269 median for compounded tirzepatide across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price includes the medication, clinician visits and shipping
  • ✓We found no FDA warning letters issued to Bloom MD

Cons

  • ✗Semaglutide costs $270 a month, 36% above the $199 median for compounded semaglutide across the sellers we compare
  • ✗Liraglutide costs $395 a month, 147% above the $160 median for compounded liraglutide across the sellers we compare
  • ✗Serves only 39 states and DC, so check that yours is one of them
  • ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
  • ✗Its compounded liraglutide, semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Starting from $395/moRead full review →
Visit Bloom MD →
3

Alloy

Best for: compounded liraglutide, a daily injection

7.0
Score breakdown, pros and cons

Alloy is a menopause care company, and its Weight Care program prescribes brand and compounded GLP-1 drugs to women in midlife. On the brand side it offers Zepbound, the Foundayo pill, and Wegovy as a pen or a pill; compounded semaglutide, tirzepatide and liraglutide are also offered. Every option carries a $99 monthly care fee on top of the drug, so compounded semaglutide comes to $169 a month. Code STARTGLP1 takes $50 off the first month's fee.

Score Breakdown

Value25%
7.2
Effectiveness25%
10
User Experience15%
3
Trust & Safety15%
5
Accessibility10%
9.7
Support10%
5

Pros

  • ✓Semaglutide costs $169 a month, 15% below the $199 median for compounded semaglutide across the sellers we compare
  • ✓Tirzepatide costs $199 a month, 26% below the $269 median for compounded tirzepatide across the sellers we compare
  • ✓Serves 48 states and DC
  • ✓We found no FDA warning letters issued to Alloy

Cons

  • ✗Liraglutide costs $214 a month, 34% above the $160 median for compounded liraglutide across the sellers we compare
  • ✗You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
  • ✗Its compounded liraglutide, semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Starting from $214/moRead full review →
Visit Alloy →
4

ShapeIn Rx

Best for: compounded liraglutide, a daily injection

6.9
Score breakdown, pros and cons

WellHealth LLC, an Arizona company, runs ShapeIn Rx and sells compounded semaglutide with B12 and daily compounded liraglutide. Semaglutide costs $179 for doses through 1 mg and $299 through 2.5 mg; liraglutide starts at $149. Shipping ($29) and a one-time $45 appointment are extra. It names Compounding Pharmacy of America as its pharmacy and serves only states where its providers are licensed.

Score Breakdown

Value25%
5.8
Effectiveness25%
9
User Experience15%
8
Trust & Safety15%
8
Accessibility10%
5
Support10%
3

Pros

  • ✓Semaglutide costs $179 a month, 10% below the $199 median for compounded semaglutide across the sellers we compare
  • ✓Liraglutide costs $149 a month, close to the $160 median for compounded liraglutide across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price includes the medication
  • ✓Names Compounding Pharmacy of America as the pharmacy that fills its prescriptions, which most sellers do not
  • ✓We found no FDA warning letters issued to ShapeIn Rx

Cons

  • ✗Not included in the monthly price: clinician visits, shipping
  • ✗Confirm it serves your state before you start the intake
  • ✗Its liraglutide and semaglutide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Starting from $149/moRead full review →
Visit ShapeIn Rx →
5

Hone Health

Best for: compounded liraglutide, a daily injection

5.9
Score breakdown, pros and cons

Hone Health is a comprehensive longevity telehealth platform for men and women, covering hormone optimization, weight management, sexual health, and metabolic health. Its weight loss formulary is compounded liraglutide at $160/mo, naltrexone at $60/mo, bupropion at $60/mo, phentermine at $65/mo, topiramate at $65/mo, and sermorelin at $130/mo. All of them require a membership, either $25/mo Basic or $149/mo Premium.

Score Breakdown

Value25%
5
Effectiveness25%
6.5
User Experience15%
7
Trust & Safety15%
6.5
Accessibility10%
5
Support10%
5

Pros

  • ✓Liraglutide costs $160 a month for the medication, plus a required membership, exactly the $160 median for compounded liraglutide across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓We found no FDA warning letters issued to Hone Health
  • ✓A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
  • ✓Baseline bloodwork is required before a prescription

Cons

  • ✗Confirm it serves your state before you start the intake
  • ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
  • ✗Its liraglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Starting from $160/moRead full review →
Visit Hone Health →
How we rank, and what counts as “legit”

Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.

Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].

How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].

Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Related research

The board lists who sells it and at what price. These pages cover the generics, the label and how liraglutide compares with the weekly drugs.

Frequently Asked Questions

Yes. FDA has approved generic liraglutide injections, and DailyMed carries generic labels that match Saxenda's weight-management indication as well as ones that match Victoza's diabetes indication. A pharmacy can substitute one for the brand when the prescription allows it, though supply is still tight.
No. In the STEP 8 trial, weekly semaglutide 2.4 mg produced 15.8% average weight loss against 6.4% for daily liraglutide 3 mg. Liraglutide is older, cheaper as a generic and taken every day, and those are the reasons people choose it.
Both are liraglutide made by Novo Nordisk. Saxenda, at up to 3 mg a day, is labeled for weight in adults and for children from 12 upward who have obesity and a body weight over 60 kg. Victoza is approved to control blood sugar in type 2 diabetes and to cut cardiovascular risk in adults with type 2 diabetes and heart disease.
FDA's shortage database lists Saxenda as available until its discontinuation in January 2027. Generic liraglutide for the same indication is approved and sold by several manufacturers.
No compounded drug is FDA-approved, and nobody at FDA checked a compounded liraglutide for quality, safety or effect before it was shipped to you. Ask the seller to name the compounding pharmacy and to say whether it works under section 503A or 503B.
Six weighted dimensions produce the score. Value (25%) and Effectiveness (25%) carry the most, then User Experience (15%) and Trust & Safety (15%), then Accessibility (10%) and Support (10%). Behind them sits our research into pricing data, clinical evidence, user reviews and publicly available information. Those weights then combine into one overall score out of 10.
The six-dimension methodology computes each score on its own, and no commercial relationship ever moves a provider's underlying number. Every provider's full score sits on its card for you to check. Some providers do hold affiliate agreements with us, which means a commission reaches us if you click through and buy. On the lists carrying the highest commercial intent — the weight-loss injection and shot lists, the semaglutide and tirzepatide lists, the compounded and cheapest molecule lists, and the fitness-app list — affiliate partners take the top positions. Every other list runs in score order, or in price order on the cheapest lists. That placement is disclosed here, on our methodology page, and on our affiliate-disclosure page.
Sources & methodology — as of November 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  5. 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  8. 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
  9. 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  10. 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
  11. 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
  12. 12.SCALE Obesity and Prediabetes Trial — A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (Pi-Sunyer X et al.)— New England Journal of Medicine.PMID: 26132939.
  13. 13.STEP 8 Trial — Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (Rubino DM et al.)— JAMA.PMID: 35015037.
  14. 14.FDA Drug Shortages: Liraglutide Injection (Currently in Shortage, first posted July 18, 2023)— U.S. Food and Drug Administration.
  15. 15.Saxenda (liraglutide) prescribing information, DailyMed SPL— Novo Nordisk, via the National Library of Medicine (DailyMed).

Related Rankings